L. Campion

9.5k total citations
185 papers, 6.2k citations indexed

About

L. Campion is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, L. Campion has authored 185 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 59 papers in Pulmonary and Respiratory Medicine and 43 papers in Surgery. Recurrent topics in L. Campion's work include Prostate Cancer Treatment and Research (26 papers), Breast Cancer Treatment Studies (24 papers) and Prostate Cancer Diagnosis and Treatment (22 papers). L. Campion is often cited by papers focused on Prostate Cancer Treatment and Research (26 papers), Breast Cancer Treatment Studies (24 papers) and Prostate Cancer Diagnosis and Treatment (22 papers). L. Campion collaborates with scholars based in France, United States and Germany. L. Campion's co-authors include Mario Campone, Catherine Guérin‐Charbonnel, Wilfried Gouraud, Françoise Kraeber‐Bodéré, Pascal Jézéquel, Jean‐François Chatal, Jacques Barbet, Gabriel Ricolleau, Philippe Moreau and Caroline Rousseau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

L. Campion

175 papers receiving 6.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
L. Campion	2.2k	1.9k	1.4k	1.2k	1.1k	185	6.2k
David Boulware	1.6k 0.7×	1.5k 0.8×	845 0.6×	924 0.8×	324 0.3×	122	5.4k
Cristina Nanni	1.2k 0.5×	2.1k 1.1×	799 0.6×	2.6k 2.2×	2.7k 2.4×	257	7.7k
N. J. O’Higgins	2.2k 1.0×	2.8k 1.5×	2.9k 2.0×	670 0.6×	644 0.6×	185	6.8k
Eleni Efstathiou	2.0k 0.9×	2.4k 1.3×	1.7k 1.2×	4.7k 3.9×	1.3k 1.1×	203	7.4k
Kouros Owzar	1.3k 0.6×	1.4k 0.8×	558 0.4×	2.2k 1.9×	418 0.4×	150	5.9k
Aristotelis Bamias	1.7k 0.7×	3.1k 1.6×	829 0.6×	2.2k 1.9×	471 0.4×	276	6.9k
Robert Justice	2.8k 1.3×	2.5k 1.3×	871 0.6×	1.7k 1.4×	465 0.4×	61	6.4k
Peter Venner	1.9k 0.9×	3.3k 1.7×	1.5k 1.1×	4.8k 4.0×	711 0.6×	116	8.4k
Junji Uchida	1.3k 0.6×	2.2k 1.2×	869 0.6×	1.8k 1.5×	657 0.6×	251	6.4k
Gloria Broadwater	1.2k 0.5×	3.1k 1.6×	1.8k 1.3×	1.0k 0.8×	656 0.6×	182	6.2k

Countries citing papers authored by L. Campion

Since Specialization

Citations

This map shows the geographic impact of L. Campion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Campion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Campion more than expected).

Fields of papers citing papers by L. Campion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Campion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Campion. The network helps show where L. Campion may publish in the future.

Co-authorship network of co-authors of L. Campion

This figure shows the co-authorship network connecting the top 25 collaborators of L. Campion. A scholar is included among the top collaborators of L. Campion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Campion. L. Campion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Classe, Jean‐Marc, L. Campion, Fabrice Lécuru, et al.. (2024). Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial.. Journal of Clinical Oncology. 42(17_suppl). LBA5505–LBA5505. 8 indexed citations

Campion, L., et al.. (2024). ATYPICAL PRESENTATION OF DRESS SYNDROME IN AN AFRICAN AMERICAN MALE. Annals of Allergy Asthma & Immunology. 133(6). S104–S105.

Campion, L., E. Meyer, P. Pommier, et al.. (2024). Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial. European Urology Oncology. 8(1). 38–46. 3 indexed citations

Guérin‐Charbonnel, Catherine, Jean-Baptiste Alberge, Magali Devic, et al.. (2023). Exploring the impact of dexamethasone on gene regulation in myeloma cells. Life Science Alliance. 6(9). e202302195–e202302195. 3 indexed citations

Classe, Jean‐Marc, Pierre Méeus, Éric Leblanc, et al.. (2023). #876 Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: the chipor randomised phase III trial. A29.1–A29. 4 indexed citations

Rousseau, Caroline, David M. Goldenberg, Ludovic Ferrer, et al.. (2020). Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer. Journal of Nuclear Medicine. 61(8). 1205–1211. 28 indexed citations

Dumont, Frédéric, Hélène Senellart, F Pein, et al.. (2018). Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design. PubMed. 3(3). 20180120–20180120. 26 indexed citations

Bennouna, Jaafar, Thierry André, L. Campion, et al.. (2018). Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer—A UNICANCER GI-PRODIGE Trial. Clinical Colorectal Cancer. 18(1). e69–e73. 14 indexed citations

Magrangeas, Florence, Rowan Kuiper, Hervé Avet‐Loiseau, et al.. (2016). A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma. Clinical Cancer Research. 22(17). 4350–4355. 30 indexed citations

10.

Campone, Mario, Isabelle Valo, Pascal Jézéquel, et al.. (2015). Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples. Molecular & Cellular Proteomics. 14(11). 2936–2946. 41 indexed citations

11.

Montagna, Maria Teresa, Grazia Lovero, Elisa Borghi, et al.. (2014). Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013.. PubMed. 18(5). 661–74. 69 indexed citations

12.

Malleter, Marine, Sébastien Tauzin, Alban Bessede, et al.. (2013). CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer. Cancer Research. 73(22). 6711–6721. 69 indexed citations

13.

Salaün, Pierre‐Yves, L. Campion, Claire Bournaud, et al.. (2012). Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement. Journal of Nuclear Medicine. 53(8). 1185–1192. 44 indexed citations

14.

Campone, Mario, Cécile Couriaud, Morgan Grau, et al.. (2011). c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1. Molecular Cancer. 10(1). 110–110. 34 indexed citations

15.

Avet‐Loiseau, Hervé, Florent Malard, L. Campion, et al.. (2010). Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?. Blood. 117(6). 2009–2011. 92 indexed citations

16.

Avet‐Loiseau, Hervé, Xavier Leleu, Murielle Roussel, et al.. (2010). Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p). Journal of Clinical Oncology. 28(30). 4630–4634. 298 indexed citations

17.

Hervouet, Éric, Emilie Debien, L. Campion, et al.. (2009). Folate Supplementation Limits the Aggressiveness of Glioma via the Remethylation of DNA Repeats Element and Genes Governing Apoptosis and Proliferation. Clinical Cancer Research. 15(10). 3519–3529. 59 indexed citations

18.

Decaux, Olivier, Laurence Lodé, Florence Magrangeas, et al.. (2008). Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome. Journal of Clinical Oncology. 26(29). 4798–4805. 269 indexed citations

19.

Marchal, Frédéric, et al.. (2005). Post-operative care and patient satisfaction after ambulatory surgery for breast cancer patients. European Journal of Surgical Oncology. 31(5). 495–499. 54 indexed citations

20.

Maugard, Christine M., et al.. (2001). Genetic polymorphism at the glutathione S‐tranferase (GST) P1 locus is a breast cancer risk modifier. International Journal of Cancer. 91(3). 334–339. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact